Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
An actinomycete strain No. Q996-17 produced a novel compound, epoxomicin, which exhibited in vivo antitumor activity against B16 melanoma. Structural studies indicated that it is a new member of the epoxy-beta-aminoketone group, and is closely related to eponemycin.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on